Relationship among beta-adrenergic blockade, propranolol concentration, and liver function in patients with cirrhosis.
In 20 patients with cirrhosis we studied the relationship among the efficiency of beta-adrenergic blockade induced by oral administration of 40 mg propranolol, the plasma level of propranolol, and the liver function. The beta-adrenergic blockade was studied 2 h and 8 h after propranolol administration and assessed by the cardiac chronotropic response to isoprenaline. Liver function was evaluated by a standard liver function test and the Child-Turcotte or Pugh score. The beta-adrenergic blockade and propranolol plasma concentration were higher 2 h than 8 h after propranolol administration. The beta-adrenergic blockade and the propranolol plasma concentration varied widely among patients. No significant correlation was found between the efficiency of beta-blockade and propranolol concentration. The beta-adrenergic response before propranolol administration was correlated with bilirubin level and Child scores, but no significant correlation was found between the beta-blockade and the severity of liver disease. These results suggest that in patients with cirrhosis, differences in response to propranolol are not related to differences in the severity of the liver disease or to differences in propranolol concentration.
Caujolle
B
B
INSERM Hepatology Unit, Hôpital Saint-Antoine, Paris, France.
Ballet
F
F
Poupon
R
R
D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008103:Liver Cirrhosis / Q000097:blood / Q000188:drug therapy*; D008104:Liver Cirrhosis, Alcoholic / Q000097:blood / Q000188:drug therapy; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000097:blood / Q000627:therapeutic use*
D011433:Propranolol; D007545:Isoproterenol